Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Anebulo Pharmaceuticals Inc
(NQ:
ANEB
)
1.980
-0.060 (-2.95%)
Streaming Delayed Price
Updated: 11:48 AM EDT, Aug 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Anebulo Pharmaceuticals Inc
< Previous
1
2
3
Next >
Anebulo is Developing an Antidote to Cannabis Intoxication
September 07, 2021
The company Anebulo Pharmaceuticals (NASDAQ: ANEB) is investing in an antidote for cannabis intoxication. The social and medical issues associated with acute cannabis intoxication...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Treatment of Cannabis Toxicity
August 30, 2021
The increasing prevalence and potency of cannabis following the legalization of recreational marijuana sales in a number of states have also increa...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 25, 2021
Gainers Ascendis Pharma (NASDAQ:ASND) st...
Via
Benzinga
Cannabis Legalization is Driving an Increase in Related ER Visits
August 23, 2021
The legalization of both medical use and recreational use of cannabis in the United States has lead to an increase in both availability and potency...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Alcohol, Cannabis and Synergistic Risk
August 16, 2021
Although cannabis use is considered relatively benign, there is an increasing appreciation of the
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Movers & Shakers: Creo, Harvest Health & Recreation, Glass House, Flora Growth, Anebulo, Cannformatics, Republic Brands
August 13, 2021
Creo Taps Graeme Kenny To Serve As New CRO Cannabinoid ingredient company Creo has appointed Graeme Kenny as i...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Over-Intoxication Results in Millions of Visits to the ER per Year
August 09, 2021
The burden on the healthcare system from cannabis use is often underappreciated, because many see the risks of smoking marijuana as low. However, t...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Danger of Synthetic Cannabinoids
July 26, 2021
A problem of increasing social importance is the rise in the use of synthetic cannabis alternatives, commonly called K2 or Spice or a number of oth...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Underappreciated Risk Of Pediatric Cannabis Overdose
August 03, 2021
There are major risks associated with the consumption of large amounts of cannabis by young children. Unlike in adults, the risks to children
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Dark Side of Cannabis Legalization and one Biotech Company's Solution
July 12, 2021
Photo credits: Tim Foster As of July 2021, 18 states have legalized recreational marijuana while another 18 have legalized cannabis solel...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabinoid-Focused Anebulo Pharma Posts Q3 Earnings, On Schedule To Start Cannabis Overdose Clinical Trials
June 22, 2021
Cannabinoid-focused biotech company Anebulo Pharmaceuticals, Inc. (NASDAQ:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Daily Biotech Pulse: Moderna's Vaccine Authorized In Japan, Neovasc's Adverse Ruling In Germany, Metacrine Rallies On Insider Buying
May 21, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 20) Alexion Pharmaceuticals, Inc...
Via
Benzinga
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes
May 31, 2021
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-...
Via
Benzinga
Exposures
Product Safety
Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2021
May 25, 2021
Upgrades For Appian Corp (NASDAQ:APPN), Macquarie upgraded the previous rating of Underperform to Neutral. For the first quarter, Appian had an EPS of $0.06, compared to...
Via
Benzinga
48 Biggest Movers From Friday
May 24, 2021
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 127.3% to close at $60.00 on Friday after the company announced new results from a Phase 2 study evaluating its lead drug...
Via
Benzinga
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.